Exosomes (EXs) are cell-derived vesicles that mediate cell-cell communication and could serve as biomarkers. Here we described novel methods for purification and phenotyping of EXs released from endothelial cells (ECs) and endothelial progenitor cells (EPCs) by combining microbeads and fluorescence quantum dots (Q-dots®) techniques. EXs from the culture medium of ECs and EPCs were isolated and detected with cell-specific antibody conjugated microbeads and second antibody conjugated Q-dots by using nanoparticle tracking analysis (NTA) system. The sensitivities of the cell origin markers for ECs (CD105, CD144) and EPCs (CD34, KDR) were evaluated. The sensitivity and specificity were determined by using positive and negative markers for EXs (CD63), platelets (CD41), erythrocytes (CD235a), and microvesicles (Annexin V). Moreover, the methods were further validated in particle-free plasma and patient samples. Results showed that anti-CD105/anti-CD144 and anti-CD34/anti-KDR had the highest sensitivity and specificity for isolating and detecting EC-EXs and EPC-EXs, respectively. The methods had the overall recovery rate of over 70% and were able to detect the dynamical changes of circulating EC-EXs and EPC-EXs in acute ischemic stroke. In conclusion, we have developed sensitive and specific microbeads/Q-dots fluorescence NTA methods for EC-EX and EPC-EX isolation and detection, which will facilitate the functional study and biomarker discovery.
Accurate analysis of specific microvesicles (MVs) from biofluids is critical and challenging. Here we described novel methods to purify and detect MVs shed from endothelial cells (ECs) and endothelial progenitor cells (EPCs) by combining microbeads with fluorescence quantum dots (Q-dots) coupled nanoparticle tracking analysis (NTA). In the in vitro screening systems, we demonstrated that 1) anti-CD105 (EC marker) and anti-CD34 (EPC marker) conjugated-microbeads had the highest sensitivity and specificity for isolating respective MVs, which were confirmed with negative controls, CD41 and CD235a; 2) anti-CD144 (EC marker) and anti-KDR (EPC marker) conjugated-Q-dots exhibited the best sensitivity and specificity for their respective MV NTA detection, which were confirmed with positive control, anti-Annexin V (MV universal marker). The methods were further validated by their ability to efficiently recover the known amount of EC-MVs and EPC-MVs from particle-depleted plasma, and to detect the dynamical changes of plasma MVs in ischemic stroke patients, as compared with traditional flow cytometry. These novel methods provide ideal approaches for functional analysis and biomarker discovery of ECs- and EPCs- derived MVs.
Estrogens have previously been shown to protect the brain against acute
ischemic insults, by potentially augmenting cerebrovascular function after
ischemic stroke. The current study hypothesized that treatment with sustained
release of high-dose 17β-estradiol (E2) at the time of reperfusion from
middle cerebral artery occlusion (MCAO) in rats would attenuate reperfusion
injury, augment post-stroke angiogenesis and cerebral blood flow, and attenuate
lesion volume. Female Wistar rats underwent ovariectomy, followed two weeks
later by transient, two-hour right MCAO (tMCAO) and treatment with E2 (n = 13)
or placebo (P; n = 12) pellets starting at reperfusion. E2 treatment resulted in
significantly smaller total lesion volume, smaller lesions within striatal and
cortical brain regions, and less atrophy of the ipsilateral hemisphere after six
weeks of recovery. E2-treated animals exhibited accelerated recovery of
contralateral forelimb sensorimotor function in the cylinder test. Magnetic
resonance imaging (MRI) showed that E2 treatment reduced the formation of lesion
cysts, decreased lesion volume, and increased lesional cerebral blood flow
(CBF). Ktrans, a measure of vascular permeability, was increased in
the lesions. This finding, which represents lesion neovascularization, was not
altered by E2 treatment. Ischemic stroke–related angiogenesis and vessel
formation was confirmed with immunolabeling of brain tissue and was not altered
with E2 treatment. In summary, E2 treatment administered immediately following
reperfusion significantly reduced lesion size, cyst formation, and brain atrophy
while improving lesional CBF and accelerating recovery of functional deficits in
a rat model of ischemic stroke.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.